Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae

N Engl J Med. 2019 Feb 21;380(8):791-793. doi: 10.1056/NEJMc1807634.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy
  • Carbapenem-Resistant Enterobacteriaceae*
  • Colistin / therapeutic use
  • Creatinine / blood
  • Drug Resistance, Bacterial
  • Enterobacteriaceae Infections / complications
  • Enterobacteriaceae Infections / drug therapy*
  • Enterobacteriaceae Infections / mortality
  • Healthcare-Associated Pneumonia / drug therapy
  • Humans
  • Intention to Treat Analysis
  • Kaplan-Meier Estimate
  • Pneumonia, Bacterial / drug therapy
  • Pneumonia, Ventilator-Associated / drug therapy
  • Sample Size
  • Sisomicin / analogs & derivatives*
  • Sisomicin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Creatinine
  • plazomicin
  • Sisomicin
  • Colistin